FR2100716B1 - - Google Patents

Info

Publication number
FR2100716B1
FR2100716B1 FR7119993A FR7119993A FR2100716B1 FR 2100716 B1 FR2100716 B1 FR 2100716B1 FR 7119993 A FR7119993 A FR 7119993A FR 7119993 A FR7119993 A FR 7119993A FR 2100716 B1 FR2100716 B1 FR 2100716B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7119993A
Other languages
French (fr)
Other versions
FR2100716A1 (hr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STATENS BAKTERIOLOGISKA
Original Assignee
STATENS BAKTERIOLOGISKA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STATENS BAKTERIOLOGISKA filed Critical STATENS BAKTERIOLOGISKA
Publication of FR2100716A1 publication Critical patent/FR2100716A1/fr
Application granted granted Critical
Publication of FR2100716B1 publication Critical patent/FR2100716B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7119993A 1970-06-02 1971-06-02 Expired FR2100716B1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (hr) 1970-06-02 1970-06-02

Publications (2)

Publication Number Publication Date
FR2100716A1 FR2100716A1 (hr) 1972-03-24
FR2100716B1 true FR2100716B1 (hr) 1975-06-06

Family

ID=20271889

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7119993A Expired FR2100716B1 (hr) 1970-06-02 1971-06-02

Country Status (8)

Country Link
AT (1) AT309678B (hr)
CA (1) CA960964A (hr)
CH (1) CH572745A5 (hr)
DE (1) DE2127159C2 (hr)
FR (1) FR2100716B1 (hr)
GB (1) GB1344340A (hr)
NL (1) NL177599C (hr)
SE (1) SE348942B (hr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE389596B (sv) * 1974-06-14 1976-11-15 P G S Lindroos Saett att ur en vaetska innehallande blodsubstanser separera jaernfoereningar fran globin
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
US4315851A (en) 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
AU2010205007A1 (en) * 2009-01-13 2011-07-07 Ge Healthcare Bio-Sciences Ab Precipitation of biomolecules with negatively charged polymers
MY157239A (en) 2009-05-27 2016-05-13 Baxalta Inc A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
MX349005B (es) 2011-08-26 2017-07-06 Baxalta Inc Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma.
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
MX369444B (es) 2012-02-29 2019-11-08 Baxalta Inc REMIELINIZACION DE NERVIOS PERIFERICOS ESTIMULADA POR IgG.
EP2961426B1 (en) 2013-02-26 2019-10-30 Baxalta GmbH Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
HUE044737T2 (hu) 2013-05-06 2019-11-28 Baxalta Inc Alzheimer-kór szubpopulációk kezelése egyesített immunglubulin G-vel
WO2023170553A1 (en) 2022-03-07 2023-09-14 Takeda Pharmaceutical Company Limited Affinity chromatographic production of clinical human igg products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (hr) * 1962-01-03
BE713764A (hr) * 1967-05-01 1968-09-16 Baxter Travenol Lab
AT275038B (de) * 1967-11-15 1969-10-10 Immuno Ag Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen

Also Published As

Publication number Publication date
CH572745A5 (hr) 1976-02-27
DE2127159C2 (de) 1981-12-24
GB1344340A (en) 1974-01-23
SE348942B (hr) 1972-09-18
NL7107529A (hr) 1971-12-06
NL177599C (nl) 1985-10-16
DE2127159A1 (de) 1971-12-09
CA960964A (en) 1975-01-14
FR2100716A1 (hr) 1972-03-24
AT309678B (de) 1973-08-27
NL177599B (nl) 1985-05-17

Similar Documents

Publication Publication Date Title
AR204384A1 (hr)
FR2100716B1 (hr)
ATA96471A (hr)
AU1146470A (hr)
AU2130570A (hr)
AR195465A1 (hr)
AU1064870A (hr)
AU1872870A (hr)
AU2112570A (hr)
AU1004470A (hr)
AU2115870A (hr)
AU2144270A (hr)
AU1083170A (hr)
AU1086670A (hr)
AU2119370A (hr)
ATA672271A (hr)
AU1841070A (hr)
AU1189670A (hr)
AU1235770A (hr)
AU1247570A (hr)
AU1277070A (hr)
AU2130770A (hr)
AU2131570A (hr)
AU1881070A (hr)
CH572516A5 (hr)